| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
CommunityCare, one of the largest health care companies in Oklahoma, is locally owned and operated by Saint Francis Health System and St. John Health System in Tulsa. CommunityCare offers a wide variety of group and individual products, including HMO, HRA, POS and PPO plans, Medicare Advantage plans, Medicare supplement plans, an employee assistance program and a workers` compensation plan. CommunityCare is proud to be Oklahoma`s best choice for health care.
Quality Progressions is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Inter Parfums, Inc. operates in the fragrance business, and manufactures, markets and distributes an array of fragrances and fragrance related products.
Oasis For Orphans (o4o.org) is a non-profit organization dedicated to giving children in Kenya hope for a bright future. We believe that education is the key to unlocking opportunities, but when physical and educational needs are not met, the future be...